Huiqing Jiang Selected Research

Huiqing Jiang Research Topics

Disease

9	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021 - 07/2010
8	Neoplasms (Cancer) 04/2024 - 04/2009
4	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2009
3	Inflammation (Inflammations) 01/2023 - 01/2019
3	Liver Neoplasms (Liver Cancer) 03/2022 - 01/2013
2	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2016
2	End Stage Liver Disease 01/2023 - 11/2018
2	Hemorrhage 11/2022 - 03/2022
2	Carcinogenesis 01/2022 - 12/2018
1	Acute-On-Chronic Liver Failure 10/2023
1	Stomach Neoplasms (Stomach Cancer) 07/2023
1	Reperfusion Injury 01/2023
1	Esophageal Achalasia (Megaesophagus) 11/2022
1	Colonic Neoplasms (Colon Cancer) 04/2022
1	Esophageal and Gastric Varices (Esophageal Varices) 03/2022
1	Testicular Neoplasms (Testicular Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Pancreatitis 11/2021
1	Pancreas Divisum 11/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Fibrosis (Cirrhosis) 01/2017
1	Liver Diseases (Liver Disease) 03/2016
1	Necrosis 03/2016
1	Cholangiocarcinoma 01/2015
1	Esophageal Neoplasms (Esophageal Cancer) 07/2013
1	Diabetes Mellitus 01/2013
1	Insulin Resistance 01/2013
1	Obesity 01/2013
1	Hepatopulmonary Syndrome 07/2012
1	Jaundice (Icterus) 01/2010
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2010

Drug/Important Bio-Agent (IBA)

4	CollagenIBA 01/2019 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 04/2022
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
3	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2019 - 01/2017
3	Phosphatidylethanolamine Binding ProteinIBA 01/2015 - 04/2009
2	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2015
2	Cytidine Triphosphate (CTP)IBA 01/2023 - 11/2018
2	BilirubinIBA 03/2022 - 01/2010
2	MicroRNAs (MicroRNA)IBA 02/2022 - 01/2013
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2019 - 07/2010
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 07/2013
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2017 - 03/2014
2	Sorafenib (BAY 43-9006)FDA Link 03/2016 - 07/2010
2	Messenger RNA (mRNA)IBA 01/2015 - 07/2013
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2010 - 04/2009
1	Immune Checkpoint InhibitorsIBA 07/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2023
1	apatinibIBA 07/2023
1	Programmed Cell Death 1 ReceptorIBA 07/2023
1	SodiumIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	BariumIBA 11/2022
1	AntigensIBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	CateninsIBA 01/2022
1	LigandsIBA 12/2021
1	PlasticsIBA 11/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	Thioacetamide (Thioacetamid)IBA 01/2021
1	Superoxide DismutaseIBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Malondialdehyde (Propanedial)IBA 01/2019
1	locostatinIBA 01/2019
1	CytokinesIBA 01/2019
1	Small Untranslated RNAIBA 12/2018
1	Piwi-Interacting RNAIBA 12/2018
1	KLA peptideIBA 09/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Keratin-19 (Keratin 19)IBA 01/2015
1	Tissue Inhibitor of Metalloproteinase-4IBA 01/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2015
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2014
1	GTP-Binding Proteins (G-Protein)IBA 07/2013
1	GhrelinIBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	LeptinIBA 01/2013
1	IH 764-3 (764-3)IBA 12/2012
1	salicylhydroxamic acid (SHAM)IBA 07/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2010
1	Therapeutic UsesIBA 07/2010
1	Platelet-Derived Growth FactorIBA 07/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2010
1	Tight Junction ProteinsIBA 01/2010
1	Mitogen-Activated Protein KinasesIBA 04/2009

Therapy/Procedure

6	Ligation 03/2022 - 07/2012
3	Therapeutics 09/2017 - 01/2013
1	Immunotherapy 04/2024
1	Myotomy 11/2022
1	Stents 11/2021
1	Radiotherapy 01/2016
1	Drug Therapy (Chemotherapy) 01/2013